rs1215612827
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_006415.4(SPTLC1):c.985C>T(p.Arg329*) variant causes a stop gained, splice region change. The variant allele was found at a frequency of 0.0000248 in 1,613,406 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_006415.4 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Publications
- amyotrophic lateral sclerosis 27, juvenileInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- neuropathy, hereditary sensory and autonomic, type 1AInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hereditary sensory and autonomic neuropathy type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SPTLC1 | NM_006415.4 | c.985C>T | p.Arg329* | stop_gained, splice_region_variant | Exon 11 of 15 | ENST00000262554.7 | NP_006406.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152156Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 251046 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461250Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 726966 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152156Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74322 show subpopulations
ClinVar
Submissions by phenotype
Neuropathy, hereditary sensory and autonomic, type 1A Pathogenic:1
- -
Charcot-Marie-Tooth disease Uncertain:1
- -
Hereditary sensory and autonomic neuropathy type 1 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in SPTLC1 cause disease. This variant has not been reported in the literature in individuals with SPTLC1-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg329*) in the SPTLC1 gene. It is expected to result in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at